The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management. Read this story
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management. Read this story
More from CNBC | Breaking News: Business Johnson & Johnson Health care industry Pharmaceuticals Biotech and Pharmaceuticals Biotechnology Business business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source Talc Ovarian cancer